|
INZY Inozyme Pharma Inc 1693011 |
| Balance Sheet |
|
Current Assets
|
140,937,000 |
|
Assets
|
143,361,000 |
|
Current Liabilities
|
18,344,000 |
|
Liabilities
|
60,573,000 |
|
Equity
|
82,788,000 |
|
Shares Out
|
62,734,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-72,719,000 |
|
Investing Cash Flow
|
51,558,000 |
| Market Analysis |
Market Cap
|
368,250,920 |
|
Price
|
1.36 |
|
BVPS
|
1.32 |
|
PB
|
1.03 |
|
EPS
|
-1.46 |
|
PS
|
2.08 |
|
FCF
|
-21,161,000 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view INZY documents filed with the SEC.
INZY Filings
Clear
